AptaBio Therapeutics Statistics
Total Valuation
KOSDAQ:293780 has a market cap or net worth of KRW 210.48 billion. The enterprise value is 193.53 billion.
Market Cap | 210.48B |
Enterprise Value | 193.53B |
Important Dates
The next estimated earnings date is Thursday, August 14, 2025.
Earnings Date | Aug 14, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
KOSDAQ:293780 has 26.88 million shares outstanding. The number of shares has increased by 6.87% in one year.
Current Share Class | 26.88M |
Shares Outstanding | 26.88M |
Shares Change (YoY) | +6.87% |
Shares Change (QoQ) | -3.65% |
Owned by Insiders (%) | 28.45% |
Owned by Institutions (%) | 3.00% |
Float | 18.28M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 67.76 |
PB Ratio | 4.07 |
P/TBV Ratio | 4.07 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -6.91 |
EV / Sales | 62.30 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -11.71 |
Financial Position
The company has a current ratio of 1.79, with a Debt / Equity ratio of 0.15.
Current Ratio | 1.79 |
Quick Ratio | 1.59 |
Debt / Equity | 0.15 |
Debt / EBITDA | n/a |
Debt / FCF | -0.48 |
Interest Coverage | -6.79 |
Financial Efficiency
Return on equity (ROE) is -51.24% and return on invested capital (ROIC) is -19.16%.
Return on Equity (ROE) | -51.24% |
Return on Assets (ROA) | -15.63% |
Return on Invested Capital (ROIC) | -19.16% |
Return on Capital Employed (ROCE) | -36.44% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.04 |
Inventory Turnover | 26.55 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +38.34% in the last 52 weeks. The beta is 1.61, so KOSDAQ:293780's price volatility has been higher than the market average.
Beta (5Y) | 1.61 |
52-Week Price Change | +38.34% |
50-Day Moving Average | 7,362.60 |
200-Day Moving Average | 7,593.50 |
Relative Strength Index (RSI) | 55.18 |
Average Volume (20 Days) | 69,332 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KOSDAQ:293780 had revenue of KRW 3.11 billion and -27.99 billion in losses. Loss per share was -1,161.66.
Revenue | 3.11B |
Gross Profit | 220.53M |
Operating Income | -20.24B |
Pretax Income | -26.42B |
Net Income | -27.99B |
EBITDA | -19.70B |
EBIT | -20.24B |
Loss Per Share | -1,161.66 |
Balance Sheet
The company has 24.93 billion in cash and 7.97 billion in debt, giving a net cash position of 16.96 billion or 630.76 per share.
Cash & Cash Equivalents | 24.93B |
Total Debt | 7.97B |
Net Cash | 16.96B |
Net Cash Per Share | 630.76 |
Equity (Book Value) | 51.73B |
Book Value Per Share | 1,924.47 |
Working Capital | 13.02B |
Cash Flow
In the last 12 months, operating cash flow was -16.25 billion and capital expenditures -277.03 million, giving a free cash flow of -16.53 billion.
Operating Cash Flow | -16.25B |
Capital Expenditures | -277.03M |
Free Cash Flow | -16.53B |
FCF Per Share | -614.80 |
Margins
Gross Margin | 7.10% |
Operating Margin | -651.42% |
Pretax Margin | -850.35% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
KOSDAQ:293780 does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -6.87% |
Shareholder Yield | n/a |
Earnings Yield | -13.30% |
FCF Yield | -7.85% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on August 24, 2021. It was a forward split with a ratio of 2.
Last Split Date | Aug 24, 2021 |
Split Type | Forward |
Split Ratio | 2 |
Scores
KOSDAQ:293780 has an Altman Z-Score of 2.8. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.8 |
Piotroski F-Score | n/a |